Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma

Clinical trial NCT01026493 · COMPLETED

Trial details

NCT number: NCT01026493
Sponsor: Radiation Therapy Oncology Group
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 2010-07-01
Primary completion: 2014-05-01
Enrollment: 257

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.